Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study
, , , , , y
02 feb 2022
Acerca de este artículo
Publicado en línea: 02 feb 2022
Páginas: 325 - 332
Recibido: 05 oct 2020
Aceptado: 06 mar 2021
DOI: https://doi.org/10.2478/sjecr-2021-0057
Palabras clave
© 2021 Ravinder Singh et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Singh, Ravinder
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India
Rao, Harbir Kaur
Gian Sagar Medical College and HospitalPatiala
Sharma, Anil
Amil PharmaceuticalsNew Delhi
Singh, Thakur Gurjeet
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India
Parashar, Abhimanyu
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India
Singh, Randhir
MM College of Pharmacy, Maharishi Markandeshwar University MullanaAmbala, India
Saini, Balraj
Chitkara College of Pharmacy, Chitkara UniversityPunjab, India